pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • An «ideal patient» for uterine artery embolization

    Редактор | 2026, Literature reviews, Practical medicine part 24 №1. 2026 | 3 марта, 2026

    A.V. MALUSHKO1, V.R. SILAKOVA3, I.B. FATKULLINA2, I.D. SHCHEDRINA1, S.M. ALEKSEEV1

     1Leningrad region Clinical Hospital, Saint Petersburg

    2Bashkir State Medical University, Ufa

    3I.M. Sechenov First Moscow State Medical University (Sechenovskiy University), Moscow

    Contact details:

    Malushko A.V. — Head of the Gynecology Unit

    Address: 45 Prospekt Lunacharskogo, apt 2, 194291 Saint Petersburg, Russian Federation, tel.: 8-800-301-47-47, e-mail: a-malushko@mail.ru

    Uterine artery embolization (UAE) has established itself as a highly effective organ-preserving treatment for symptomatic uterine fibroids. The clinical effectiveness of the procedure is crucially dependent on the accuracy of preoperative patient selection. Based on an analysis of Russian clinical guidelines, Society of Interventional Radiology (SIR) standards, and evidence-based medicine data, this review provides a comprehensive overview of the multifactorial profile of an “ideal patient” for UAE. The authors formulate key and modifying selection criteria, develop a practical algorithm for clinicians, and analyze controversial clinical situations requiring a balanced individual approach.

    Key words: uterine artery embolization (UAE), uterine fibroids, “ideal patient”, organ-preserving treatment, clinical guidelines.

    REFERENCES

    1. Sasa H., Kaji T., Furuya K. Indications and outcomes of uterine artery embolization in patients with uterine leiomyomas. Obstet. Gynecol. Int, 2012, vol. 2012. Article ID 920831. DOI: 10.1155/2012/920831
    2. Malushko A.V., Shelygin M.S., Shelygina M.M., Smirnova M.P. Clinical features and characterization of somatic status of a patient planned for uterine artery embalization in uterine leiomyoma. Sci. Res. SCO Countries: Synergy and Integration: proceedings of the International Conference (Beijing, 12 February 2025). Beijing: Infinity, 2025. Pp. 106–112.
    3. Vo N.-J., Andrews R.T. Uterine artery embolization: a safe and effective, minimally invasive, uterine-sparing treatment option for symptomatic fibroids. Sem. Int. Radiol., 2008, vol. 25 (3), pp. 252–260. DOI: 10.1055/s-0028-1085928
    4. Dariushnia S.R., Nikolic B., Stokes L.S., Spies J.B. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J. Vasc. Int. Radiol, 2014, vol. 25 (11), pp. 1737–1747. DOI: 10.1016/j.jvir.2014.07.013
    5. Mioma matki: klinicheskiye rekomendatsii [Uterine fibroids: clinical guidelines]. Moscow: Ministerstvo zdravookhraneniya Rossiyskoy Federatsii, 2024. 65 p.
    6. Lapotko M.L. Uterine artery embolization method in the treatment of uterine fibroids. Okhrana materinstva i detstva, 2007, no. 2 (10), pp. 67–71 (in Russ.).
    7. Torubarov S.F., Sibirskaya E.V., Borovskaya K.A., Shmel′kov A.V. Embolizatsiya matochnykh arteriy: metodika, sravneniye, rezul′taty. Effektivnaya farmakoterapiya, 2024, vol. 20, no. 35, pp. 45–51 (in Russ.).
    8. Gomez-Jorge J., Keyoung A., Levy E.B., Spies J.B. Uterine artery anatomy relevant to uterine leiomyomata embolization. Cardiovasc. Int. Radiol, 2003, vol. 26 (6), pp. 522–527. DOI: 10.1007/s00270-003-2652-7
    9. Tzanis A.A., Antoniou S.A., Gkegkes I.D., Iavazzo C. Uterine artery embolization vs myomectomy for the management of women with uterine leiomyomas: a systematic review and meta-analysis. Am. J. Obstet. Gynecol, 2024, vol. 231 (2), pp. 187–195. DOI: 10.1016/j.ajog.2024.01.004
    10. Hu N.N., Kaw D., McCullough M.F. et al. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J. Vasc. Int. Radiol, 2011, vol. 22 (5), pp. 710–715.e1. DOI: 10.1016/j.jvir.2011.01.441
    11. Arthur R., Kachura J., Liu G. et al. Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve. J. Obstet. Gynaecol. Canada, 2014, vol. 36 (3), pp. 240–247. DOI: 10.1016/S1701-2163(15)30632-0
    12. Mara M., Maskova J., Fuckiova Z. et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc. Int. Radiol, 2008, vol. 31 (1), pp. 73–85. DOI: 10.1007/s00270-007-9195-2
    13. Korobova P.G., Sulima A.N., Mkrtchyan A.A. et al. Current issues of the efficacy and safety of uterine artery embolization in patients with uterine leiomyoma. Zhurnal akusherstva i zhenskikh bolezney, 2020, vol. 69, no. 2, pp. 15–22 (in Russ.). DOI: 10.17816/JOWD69215-22

    Метки: 2026, A.V. MALUSHKO, clinical guidelines, I.B. FATKULLINA, I.D. SHCHEDRINA, organ-preserving treatment, Practical medicine part 24 №1. 2026, S.M. ALEKSEEV, uterine artery embolization (UAE), uterine fibroids, V.R. SILAKOVA, “ideal patient”

    ‹  Obstetric sepsis in the context of maternal mortality  Artificial intelligence potential in ultrasound diagnostics of joints and soft tissue in rheumatic diseases ›
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©